Frederic Narbel
Profile
Frederic Andre Narbel served as a Non-Executive Director at Optibiotix Ltd., an Executive Director at Optibiotix Health Plc, and a Vice President-Sales at Agropur US, Inc. He holds a doctorate degree from Business School Lausanne.
Former positions of Frederic Narbel
Companies | Position | End |
---|---|---|
Optibiotix Ltd.
Optibiotix Ltd. BiotechnologyHealth Technology Part of Optibiotix Health Plc, Optibiotix Ltd. is a British company that develops biological products for digestive health. The company is based in Heslington, UK. The company was founded in 2012 by Stephen Patrick O'Hara, who has been the CEO since 2012. Optibiotix was acquired by Optibiotix Health Plc on August 05, 2014 for $122.72 million. | Director/Board Member | 2021-12-30 |
Agropur US, Inc.
Agropur US, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Agropur US, Inc. manufactures and supplies cheese and other dairy products. It offers cheddar, feta, mozzarella, and provolone cheeses. The company was founded in 1938 and is headquartered in Appleton, WI. | Sales & Marketing | - |
OPTIBIOTIX HEALTH PLC | Director/Board Member | - |
Training of Frederic Narbel
Business School Lausanne | Doctorate Degree |
Experiences
Positions held
Linked companies
Listed companies | 1 |
---|---|
OPTIBIOTIX HEALTH PLC | Health Technology |
Private companies | 2 |
---|---|
Agropur US, Inc.
Agropur US, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Agropur US, Inc. manufactures and supplies cheese and other dairy products. It offers cheddar, feta, mozzarella, and provolone cheeses. The company was founded in 1938 and is headquartered in Appleton, WI. | Consumer Non-Durables |
Optibiotix Ltd.
Optibiotix Ltd. BiotechnologyHealth Technology Part of Optibiotix Health Plc, Optibiotix Ltd. is a British company that develops biological products for digestive health. The company is based in Heslington, UK. The company was founded in 2012 by Stephen Patrick O'Hara, who has been the CEO since 2012. Optibiotix was acquired by Optibiotix Health Plc on August 05, 2014 for $122.72 million. | Health Technology |
- Stock Market
- Insiders
- Frederic Narbel